Sarasota, FL, Dec. 29, 2016 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “STD Diagnostics Market by Type (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing and Others) and by Testing Devices (Laboratory Devices and Point of Care Devices) for Hospitals and Other End Users - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”
. According to the report, the global STD diagnostic market
accounted for approximately USD 103.20 billion in 2015 and is expected to reach USD 166.50 by 2021, growing at a CAGR of around 8.3% between 2015 and 2021.
The term 'Sexually Transmitted Diseases' refers to a group of illnesses that can be transmitted from one person to another through the sharing of body fluids, vaginal fluids, blood, and others. The term sexually transmitted disease include more than 25-30 infectious diseases that are spread through sexual activity. Most people with STDs
have no symptoms. Without treatment, these diseases can lead to major health problems such as not being able to get pregnant (infertility), permanent brain damage, heart disease, cancer, and even death. If the patient has been exposed to a sexually transmitted disease he should visit a health clinic, hospital or doctor for testing and treatment. Common sexual transmitted diseases include chlamydia, syphilis, gonorrhea, herpes simplex virus, human papilloma virus, human immunodeficiency virus and others.Browse through 33 Market Tables and 37 Figures spread over 110 Pages and in-depth TOC on “Global STD Diagnostics Market: Type, Devices, End-User, Size, Share, Share, Analysis, Segment and Forecast 2015-2021”.Request free Sample copy of STD Diagnostics Market Report @ https://www.zionmarketresearch.com/sample/std-diagnostics-market
The sexual transmitted diagnostic test market was expected to witness the highest growth over the forecast period due to increasing percentage of HIV/HPV infected population across the globe. Furthermore, increasing the incidence of weakened immune system coupled with unprotected sex is also considered as a major governing factor which promotes the cause of sexually transmitted diseases and thus promotes the STDs diagnostic market. Moreover, increasing demand for rapid and accurate diagnostic tests and presence of favorable government initiatives for STD testing in developing countries such as Brazil, India, and China are further estimated to boost the market growth of STDs diagnostic market. However, the high cost of diagnostic test considered as a major restraining which hindered the growth of STDs diagnostic market. In addition, the unwillingness of the infected population, discontinuation of therapy coupled with the psychological impact of sexual transmitted are also considered as a key restraining factor which may curb the growth of STDs diagnostic market.
Based on the type, the global market of STD diagnostic test is bifurcated into seven types: chlamydia testing, syphilis testing, gonorrhea testing, herpes simplex virus testing, human papilloma virus testing, human immunodeficiency virus testing and others. HPV caused cervical cancer is a commonly found and most prevalent cancer among women. HPV 16 and HPV 18 is a most common causative agent which in approximately 99% of women affected by cervical cancer. Every year, around 300,000 cervical cancer deaths are registered due to HPV. The HIV segment is expected to be the fastest-growing segment of the global STD diagnostic testing market in the years to come predicted to expand at a CAGR of around 10%.
Browse the full "STD Diagnostics Market by Type (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing and Others) and by Testing Devices (Laboratory Devices and Point of Care Devices) for Hospitals and Other End Users - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021
" report at https://www.zionmarketresearch.com/report/std-diagnostics-market
Based on end-user, the global market of STD diagnostic test is bifurcated into two types: hospital and others. In the end-user segment, the hospital was the leading segment in 2015 and this segment is expected to show continuous growth during the forecast period due to the continuous rise in HPV virus across the globe.
Based on the testing device, the global market of STD diagnostic test is bifurcated into two types: laboratory testing device and point of care device. The laboratory testing device market is further segmented into thermal cyclers - PCR, lateral flow readers – immunochromatographic assays, flow cytometers, differential light scattering machines, absorbance microplate reader - Enzyme Linked Immunosorbent Assay (ELISA) and others. In testing device segment, laboratory testing was the leading segment in 2015 and this segment is projected to dominate STD diagnostic test market during the forecast period due to the continuous rise in HPV/HIV virus related infection across the globe. POC tests do not identify all STDs and many of these methods don’t follow the standard regulatory norms. Hence, laboratory methods are highly significant and reliable.Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/std-diagnostics-market
North America is expected to witness the highest growth within the forecast period owing to the favorable healthcare infrastructure, high awareness levels, and favorable government initiatives in the U.S. on STDs diagnostics. However, the demand for HPV tests has been increasing in the past few years owing to the rising awareness to analyze the growth of cancerous cell within the cervix. This is expected to fuel the market growth of STDs diagnostic test. North America accounted for approximately 40% of total market share in terms of revenue. According to the Centers for Disease Control and Prevention (CDC), 6 million people in the United States acquired HPV each year. At least 20 million already have STD, and more than half of all sexually-active adults will be infected during their lifetime. This increasing value in developed economies serves as a major driving factor for the continuous growth of in STDs diagnostics market. North American countries such as District of Columbia and West Virginia have the high prevalence of Chlamydia, P&S Syphilis and Gonorrhea and hold the largest share for testing of these infections.
Europe was the second largest leader of global STDs diagnostic test market in 2015. In 2012, UNAIDS and WHO estimated that 2.2 million people were living with HIV in the WHO European Region, including 1.3 million in eastern Europe and central Asia (EECA) representing and estimated adult prevalence of 0.7% in EECA and 0.2% in western and central Europe. European countries such as Russian federation has the high prevalence of chlamydia, P&S syphilis, herpes and gonorrhea and holds the largest share for testing of these infections.Request a customized copy of report @ https://www.zionmarketresearch.com/custom/558
Asia Pacific is expected to be the fastest growing regional segment for the STD diagnostic market in 2015 within the forecast period due to rapid spread of human papiloma virus infection among the female population in this region. Asia Pacific accounted as a leading market of the global STD diagnostic test market in 2015 in terms of growth. In addition rising awareness towards personal care in emerging economies of China and India is expected to augment the market growth of STDs diagnostic test market in the region in the near future.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global STD diagnostics market include Roche Holdings AG, Abbott Laboratories, Becton Dickinson and Company, Hologic Inc., Danaher Corporation, Affymetrix, bioMerieux, Cepheid Inc., Alere Inc., DiaSorin, and Orasure.Purchase a direct copy of report with TOC @ https://www.zionmarketresearch.com/buynow/su/std-diagnostics-marketThis report segments the global STD diagnostics market as follows:Global STD Diagnostics Market: Type Analysis
Global STD Diagnostics Market: End- User AnalysisGlobal STD Diagnostics Market: Testing Device Analysis
- Chlamydia testing
- Syphilis testing
- Gonorrhea testing
- Herpes Simplex Virus testing
- Human Papilloma Virus testing
- Human Immunodeficiency Virus testing
Global STD Diagnostics Market: Regional Segment Analysis
- Laboratory Devices
- Point of Care Devices
Related Reports:About Us:
- North America
- Asia Pacific
- Latin America
- Middle East And Africa
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-researchFollow Us Twitter: https://twitter.com/zion_research
4283, Express Lane, Suite 634-143,
Sarasota, Florida 34249, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651